OSI-7904L
OSI-7904L Uses, Dosage, Side Effects, Food Interaction and all others data.
OSI-7904L is a liposome encapsulated thymidylate synthase inhibitor, which is indicated for use in advanced gastric and/or gastroesophageal adenocarcinoma (A-G/GEJA). Current treatments also inhibit thymidylate synthase but the innovative lipid coating of OSI-7904L allows for more enduring results with administration of the TS inhibitor.
Trade Name | OSI-7904L |
Generic | OSI-7904L |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in gastric cancer.
How OSI-7904L works
Inhibits thymidylate synthase.
Toxicity
Acceptable clinical safety profile
Innovators Monograph
You find simplified version here OSI-7904L